{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:07:38Z","timestamp":1789578458875,"version":"build-2803163510"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004823","name":"Nagoya University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004823","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study aims to evaluate the impact of early steroid discontinuation on total dosage and outcomes in pediatric immunoglobulin A (IgA) vasculitis patients with uncontrolled abdominal pain. This retrospective cohort study included children younger than 16\u00a0years with newly diagnosed IgA vasculitis hospitalized for abdominal pain who received their first dose of steroids between April 1, 2013, and March 31, 2019, at 14 hospitals. Patients were divided into two groups: the standard (STD) group, which received steroid therapy for at least 8 consecutive days, and the early discontinuation attempt (EDA) group, which attempted discontinuation within 7\u00a0days. EDA was further divided into two subgroups: the early discontinuation (ED) group, which completed steroid treatment within a week, and the readministration (RA) group, which required readministration. Total steroid dosage, duration of therapy, hospital stay, and complications were compared. A total of 272 patients were analyzed: STD (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009190) and EDA (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200982). There were no significant differences in baseline characteristics. EDA had a shorter hospital stay (8.5 vs. 15.0\u00a0days,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01), fewer total steroid days (6 vs. 17.5\u00a0days,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01), and lower total steroid dosage (5.4\u00a0mg\/kg vs. 15.4\u00a0mg\/kg,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01) compared to STD, with no significant differences in complications. Among EDA patients, 22 (27%) required steroid readministration due to symptom recurrence; however, symptoms resolved in all RA patients, with lower total steroid dosage and duration compared to STD, without prolonging hospital stay.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    : Discontinuing steroids within 7\u00a0days for abdominal pain in children with IgA vasculitis reduces total steroid dosage without increasing complications, even with occasional readministration.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Clinical trial registration<\/jats:italic>\n                    : Approval no. 2019\u20130394.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td align=\"left\">\n                              <jats:bold>What is known:<\/jats:bold>\n                              \u2022\n                              <jats:italic>Steroids have been reported to be effective for abdominal pain in pediatric IgA vasculitis.<\/jats:italic>\n                              .\u2022\n                              <jats:italic>Steroids should be tapered gradually to reduce the risk of symptom flare-up in pediatric IgA vasculitis.<\/jats:italic>\n                              .\n                            <\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td align=\"left\">\n                              <jats:bold>What is new:<\/jats:bold>\n                              \u2022\n                              <jats:italic>Early discontinuation of steroids reduced total dosage and hospital stay without increasing complications in pediatric IgA vasculitis.<\/jats:italic>\n                              .\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-025-06107-7","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T13:58:52Z","timestamp":1743861532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Early discontinuation of steroid treatment in children with abdominal pain due to IgA vasculitis"],"prefix":"10.1007","volume":"184","author":[{"given":"Sumika","family":"Kambara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukina","family":"Takamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumie","family":"Kitai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuma","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Haruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Oike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marei","family":"Omori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumie","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiki","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kidokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Nagoya Collaborative Clinical Research Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuto","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Oshiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Yamamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuharu","family":"Kajita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kawabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"6107_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum 65:1\u201311","journal-title":"Arthritis Rheum"},{"key":"6107_CR2","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s10620-007-0147-0","volume":"53","author":"EC Ebert","year":"2008","unstructured":"Ebert EC (2008) Gastrointestinal manifestations of Henoch-Schonlein purpura. Dig Dis Sci 53:2011\u20132019","journal-title":"Dig Dis Sci"},{"key":"6107_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10067-020-05166-5","volume":"40","author":"L Du","year":"2021","unstructured":"Du L, Wang P, Liu C, Li S, Yue S, Yang Y (2021) Multisystemic manifestations of IgA vasculitis. Clin Rheumatol 40:43\u201352","journal-title":"Clin Rheumatol"},{"key":"6107_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jpeds.2006.03.024","volume":"149","author":"J Ronkainen","year":"2006","unstructured":"Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J et al (2006) Early prednisone therapy in Henoch-Schonlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 149:241\u2013247","journal-title":"J Pediatr"},{"key":"6107_CR5","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1542\/peds.2009-3348","volume":"126","author":"PF Weiss","year":"2010","unstructured":"Weiss PF, Klink AJ, Localio R, Hall M, Hexem K, Burnham JM et al (2010) Corticosteroids may improve clinical outcomes during hospitalization for Henoch-Schonlein purpura. Pediatrics 126:674\u2013681","journal-title":"Pediatrics"},{"key":"6107_CR6","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1542\/peds.79.6.1018","volume":"79","author":"ND Rosenblum","year":"1987","unstructured":"Rosenblum ND, Winter HS (1987) Steroid effects on the course of abdominal pain in children with Henoch-Schonlein purpura. Pediatrics 79:1018\u20131021","journal-title":"Pediatrics"},{"key":"6107_CR7","first-page":"323","volume":"31","author":"T Reinehr","year":"2000","unstructured":"Reinehr T, Burk G, Andler W (2000) Does steroid treatment of abdominal pain prevent renal involvement in Henoch-Schonlein purpura? J Pediatr Gastroenterol Nutr 31:323\u2013324","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6107_CR8","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1542\/peds.2007-0667","volume":"120","author":"PF Weiss","year":"2007","unstructured":"Weiss PF, Feinstein JA, Luan X, Burnham JM, Feudtner C (2007) Effects of corticosteroid on Henoch-Schonlein purpura: a systematic review. Pediatrics 120:1079\u20131087","journal-title":"Pediatrics"},{"key":"6107_CR9","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/ard.2009.116657","volume":"69","author":"S Ozen","year":"2010","unstructured":"Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R et al (2010) EULAR\/PRINTO\/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69:798\u2013806","journal-title":"Ann Rheum Dis"},{"key":"6107_CR10","volume-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","author":"Schimmer BP, Funder JW","year":"2011","unstructured":"Schimmer BP, Funder JW (2011) Chapter 42: ACTH, adrenal steroids, and pharmacology of the adrenal cortex. In: Brunton LL, Chabner BA, Knollmann BC (eds) Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics, 12th edn. McGraw-Hill, New York","edition":"12"},{"key":"6107_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12969-018-0247-8","volume":"16","author":"WT Lei","year":"2018","unstructured":"Lei WT, Tsai PL, Chu SH, Kao YH, Lin CY, Fang LC et al (2018) Incidence and risk factors for recurrent Henoch-Schonlein purpura in children from a 16-year nationwide database. Pediatr Rheumatol Online J 16:25","journal-title":"Pediatr Rheumatol Online J"},{"key":"6107_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1741-7015-2-7","volume":"2","author":"AM Huber","year":"2004","unstructured":"Huber AM, King J, McLaine P, Klassen T, Pothos M (2004) A randomized, placebo-controlled trial of prednisone in early Henoch Schonlein Purpura [ISRCTN85109383]. BMC Med 2:7","journal-title":"BMC Med"},{"key":"6107_CR13","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/rheumatology\/kez041","volume":"58","author":"S Ozen","year":"2019","unstructured":"Ozen S, Marks SD, Brogan P, Groot N, de Graeff N, Avcin T et al (2019) European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 58:1607\u20131616","journal-title":"Rheumatology (Oxford)"},{"key":"6107_CR14","unstructured":"Dedeoglu F, Kim S. IgA vasculitis (Henoch-Sch\u00f6nlein purpura): Management. In: Sundel R (ed) UpToDate. TePas E, ed. Waltham, MA: UpToDate Inc. https:\/\/www.uptodate.com. Accessed 30 Mar 2025"},{"key":"6107_CR15","doi-asserted-by":"publisher","first-page":"e4217","DOI":"10.1097\/MD.0000000000004217","volume":"95","author":"V Calvo-Rio","year":"2016","unstructured":"Calvo-Rio V, Hernandez JL, Ortiz-Sanjuan F, Loricera J, Palmou-Fontana N, Gonzalez-Vela MC et al (2016) Relapses in patients with Henoch-Schonlein purpura: analysis of 417 patients from a single center. Medicine (Baltimore) 95:e4217","journal-title":"Medicine (Baltimore)"},{"key":"6107_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.semarthrit.2005.08.007","volume":"35","author":"S Trapani","year":"2005","unstructured":"Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F et al (2005) Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 35:143\u2013153","journal-title":"Semin Arthritis Rheum"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06107-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06107-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06107-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T01:02:31Z","timestamp":1761699751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06107-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":16,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["6107"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06107-7","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained in the form of an opt-out on the website. Those who rejected were excluded.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"279"}}